{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:20:12Z","timestamp":1794385212557,"version":"4.9.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The presence of prion infectivity in the blood of patients affected by variant Creutzfeldt\u2013Jakob disease (v-CJD), the human prion disease linked to the bovine spongiform encephalopathy (BSE), poses the risk of inter-human transmission of this fatal prion disease through transfusion. In the frame of various experiments, we have previously described that several cynomolgus macaques experimentally exposed to prion-contaminated blood products developed c-BSE\/v-CJD, but the vast majority of them developed an unexpected, fatal disease phenotype focused on spinal cord involvement, which does not fulfill the classical diagnostic criteria of v-CJD. Here, we show that extensive analyses with current conventional techniques failed to detect any accumulation of abnormal prion protein (PrP<jats:sup>v\u2212CJD<\/jats:sup>) in the CNS of these myelopathic animals, i.e., the biomarker considered responsible for neuronal death and subsequent clinical signs in prion diseases. Conversely, in the spinal cord of these myelopathic primates, we observed an alteration of their physiological cellular PrP pattern: PrP was not detectable under its full-length classical expression but mainly under its physiological terminal-truncated C1 fragment. This observed disappearance of the N-terminal fragment of cellular PrP at the level of the lesions may provide the first experimental evidence of a link between loss of function of the cellular prion protein and disease onset. This original prion-induced myelopathic syndrome suggests an unexpected wide extension in the field of prion diseases that is so far limited to pathologies associated with abnormal changes of the cellular PrP to highly structured conformations.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1164779","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:50:06Z","timestamp":1683265806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Unexpected decrease of full-length prion protein in macaques inoculated with prion-contaminated blood products"],"prefix":"10.3389","volume":"10","author":[{"given":"Nina","family":"Jaffr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Delmotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Mikol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Deslys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Comoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","article-title":"The prion\u2019s elusive reason for being","volume":"31","author":"Aguzzi","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1111\/febs.12196","article-title":"Roles of endoproteolytic \u03b1-cleavage and shedding of the prion protein in neurodegeneration","volume":"280","author":"Altmeppen","year":"2013","journal-title":"FEBS J."},{"key":"B3","first-page":"15","article-title":"Proteolytic processing of the prion protein in health and disease","volume":"1","author":"Altmeppen","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19336896.2021.1935105","article-title":"Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease","volume":"15","author":"Andr\u00e9s-Benito","year":"2021","journal-title":"Prion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/379339a0","article-title":"Normal host prion protein necessary for scrapie-induced neurotoxicity","volume":"379","author":"Brandner","year":"1996","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.apha.2017.09.007","article-title":"Synaptotoxic signaling by amyloid beta oligomers in Alzheimer\u2019s disease through prion protein and mGluR5","volume":"82","author":"Brody","year":"2018","journal-title":"Adv. Pharmacol. San. Diego Calif."},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u201cnew variant\u201d CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","article-title":"Truncated forms of the human prion protein in normal brain and in prion diseases","volume":"270","author":"Chen","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1110837","article-title":"Anchorless prion protein results in infectious amyloid disease without clinical scrapie","volume":"308","author":"Chesebro","year":"2005","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e3017","DOI":"10.1371\/journal.pone.0003017","article-title":"Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate","volume":"3","author":"Comoy","year":"2008","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2018.1505399","article-title":"Unexpected prion phenotypes in experimentally transfused animals: Predictive models for humans?","volume":"12","author":"Comoy","year":"2018","journal-title":"Prion"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41467-017-01347-0","article-title":"Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque","volume":"8","author":"Comoy","year":"2017","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1038\/srep11573","article-title":"Transmission of scrapie prions to primate after an extended silent incubation period","volume":"5","author":"Comoy","year":"2015","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/35054134","article-title":"Screening slaughtered cattle for BSE","volume":"409","author":"Deslys","year":"2001","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1006\/mcne.2001.1049","article-title":"Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis","volume":"19","author":"Dupuis","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.142303","article-title":"Unconventional viruses and the origin and disappearance of kuru","volume":"197","author":"Gajdusek","year":"1977","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcell.2014.00044","article-title":"Prion protein and aging","volume":"2","author":"Gasperini","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"f5675","DOI":"10.1136\/bmj.f5675","article-title":"Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: Large scale survey","volume":"347","author":"Gill","year":"2013","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.3390\/ijms21176233","article-title":"N-terminal regions of prion protein: Functions and roles in prion diseases","volume":"21","author":"Hara","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"14339","DOI":"10.1128\/JVI.79.22.14339-14345.2005","article-title":"PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic creutzfeldt-jakob disease","volume":"79","author":"Herzog","year":"2005","journal-title":"J. Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0140-6736(04)15487-1","article-title":"Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection","volume":"363","author":"Herzog","year":"2004","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.06.001","article-title":"Functions of the prion protein","volume":"150","author":"Hirsch","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(00)02243-1","article-title":"Retrospective study of prion-protein accumulation in tonsil and appendix tissues","volume":"355","author":"Ironside","year":"2000","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/ijms23031232","article-title":"Prion protein: The molecule of many forms and faces","volume":"23","author":"Kova\u010d","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0304-3940(02)00668-7","article-title":"The prion protein in human neurodegenerative disorders","volume":"329","author":"Kovacs","year":"2002","journal-title":"Neurosci. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature19312","article-title":"The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6","volume":"536","author":"K\u00fcffer","year":"2016","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(05)17985-9","article-title":"Risk of oral infection with bovine spongiform encephalopathy agent in primates","volume":"365","author":"Lasmezas","year":"2005","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/381743a0","article-title":"BSE transmission to macaques","volume":"381","author":"Lasmezas","year":"1996","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1126\/science.275.5298.402","article-title":"Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein","volume":"275","author":"Lasmezas","year":"1997","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/bpa.12694","article-title":"Prion neurotoxicity","volume":"29","author":"Le","year":"2019","journal-title":"Brain Pathol. Zurich Switz."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/trf.12999","article-title":"Evaluation of the protection of primates transfused with variant creutzfeldt-jakob disease-infected blood products filtered with prion removal devices: A 5-year update","volume":"55","author":"Lescoutra-Etchegaray","year":"2015","journal-title":"Transfus. Paris."},{"key":"B33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","article-title":"Prion protein \u201cgamma-cleavage\u201d: Characterizing a novel endoproteolytic processing event","volume":"73","author":"Lewis","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/sj.emboj.7601726","article-title":"Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biolcel.2003.11.007","article-title":"Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein","volume":"96","author":"Mang\u00e9","year":"2004","journal-title":"Biol. Cell Auspices Eur. Cell Biol. Organ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1750-3639.2007.00061.x","article-title":"The role of the octarepeat region in neuroprotective function of the cellular prion protein","volume":"17","author":"Mitteregger","year":"2007","journal-title":"Brain Pathol. Zurich Switz."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jnnp.44.2.103","article-title":"Panencephalopathic type of creutzfeldt-jakob disease: Primary involvement of the cerebral white matter","volume":"44","author":"Mizutani","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"166209","DOI":"10.1016\/j.bbadis.2021.166209","article-title":"Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein","volume":"1867","author":"Nieznanska","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.20151610","article-title":"Strictly co-isogenic C57bl\/6J-prnp-\/- mice: A rigorous resource for prion science","volume":"213","author":"Nuvolone","year":"2016","journal-title":"J. Exp. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2990.2003.00544.x","article-title":"Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting","volume":"30","author":"Ritchie","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-7091-6308-5_22","article-title":"Quantitative traits of prion strains are enciphered in the conformation of the prion protein","author":"Safar","year":"2000","journal-title":"Arch. Virol. Suppl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/biomedicines10040815","article-title":"Newly identified deficiencies in the multiple sclerosis central nervous system and their impact on the remyelination failure","volume":"10","author":"Scalabrino","year":"2022","journal-title":"Biomedicines"},{"key":"B45","doi-asserted-by":"publisher","first-page":"119240","DOI":"10.1016\/j.bbamcr.2022.119240","article-title":"The prion protein and its ligands: Insights into structure-function relationships","volume":"1869","author":"Shafiq","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-004-0880-9","article-title":"Oligodendrocytes within astrocytes (\u201cemperipolesis\u201d) in the white matter in Creutzfeldt-Jakob disease","volume":"108","author":"Shintaku","year":"2004","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0092-8674(00)81572-x","article-title":"Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions","volume":"93","author":"Shmerling","year":"1998","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1096\/fj.201902588R","article-title":"Demyelinating polyneuropathy in goats lacking prion protein","volume":"34","author":"Skedsmo","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12402","article-title":"The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein","volume":"501","author":"Sonati","year":"2013","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07376.x","article-title":"An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products","volume":"144","author":"Turner","year":"2009","journal-title":"Br. J. Haematol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/molbev\/msg014","article-title":"Molecular evolution of the mammalian prion protein","volume":"20","author":"van Rheede","year":"2003","journal-title":"Mol. Biol. Evol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","article-title":"A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation","volume":"286","author":"Westergard","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","article-title":"The biological function of the cellular prion protein: An update","volume":"15","author":"Wulf","year":"2017","journal-title":"BMC Biol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1164779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:50:11Z","timestamp":1683265811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1164779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":54,"alternative-id":["10.3389\/fmolb.2023.1164779"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1164779","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmolb.2023.1164779.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmolb.2023.1164779.s002","asserted-by":"subject"}]},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1164779"}}